Your browser doesn't support javascript.
loading
Epstein-Barr Virus Induces Lymphangiogenesis and Lympth Node Metastasis via Upregulation of VEGF-C in Nasopharyngeal Carcinoma.
Li, Deng-Ke; Chen, Xing-Rui; Wang, Li-Na; Wang, Jia-Hong; Wen, Yue-Ting; Zhou, Zi-Ying; Li, Ji-Ke; Liu, Jing-Xian; Cai, Lin-Bo; Zhong, Shui-Sheng; Lyu, Xiao-Ming; Damola, Faleti Oluwasijibomi; Li, Min-Ying; Zhang, Jing-Jing; Zeng, Yu-Mei; Wang, Qian-Li; Zhang, Qian-Bing; Lyu, Hao; Fu, Xiao-Yan; Wang, Wei; Li, Xin; Huang, Zhong-Xi; Yao, Kai-Tai.
Afiliación
  • Li DK; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P.R. China.
  • Chen XR; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P.R. China.
  • Wang LN; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P.R. China.
  • Wang JH; Guangzhou First People's Hospital, School of Medicine, Southern China University of Technology, Guangzhou, P.R. China.
  • Wen YT; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P.R. China.
  • Zhou ZY; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P.R. China.
  • Li JK; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P.R. China.
  • Liu JX; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P.R. China.
  • Cai LB; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P.R. China.
  • Zhong SS; Guangdong Sanjiu Brain Hospital, Guangzhou, P.R. China.
  • Lyu XM; Guangdong Sanjiu Brain Hospital, Guangzhou, P.R. China.
  • Damola FO; Department of Laboratory Medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, P.R. China.
  • Li MY; Department of Laboratory Medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, P.R. China.
  • Zhang JJ; Department of Radiotherapy, Tumor Hospital of Zhongshan People's Hospital, Zhongshan, P.R. China.
  • Zeng YM; Department of Radiotherapy, Tumor Hospital of Zhongshan People's Hospital, Zhongshan, P.R. China.
  • Wang QL; Department of Pathology, Tumor Hospital of Zhongshan People's Hospital, Zhongshan, P.R. China.
  • Zhang QB; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, P.R. China.
  • Lyu H; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P.R. China.
  • Fu XY; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P.R. China.
  • Wang W; Department of Otorhinolaryngology Head and Neck Surgery, General Hospital of Southern Theater Command, People's Liberation Army of China, Guangzhou, P.R. China.
  • Li X; Department of Pathology, General Hospital of Southern Theater Command, People's Liberation Army of China, Guangzhou, P.R. China.
  • Huang ZX; Shenzhen Key Laboratory of Viral Oncology, the Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, P.R. China. ktyao@smu.edu.cn zxhuang@smu.edu.cn xinli268@gmail.com.
  • Yao KT; Guangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, P.R. China. ktyao@smu.edu.cn zxhuang@smu.edu.cn xinli268@gmail.com.
Mol Cancer Res ; 20(1): 161-175, 2022 01.
Article en En | MEDLINE | ID: mdl-34654722
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Virus de Epstein-Barr / Factor C de Crecimiento Endotelial Vascular / Linfangiogénesis / Carcinoma Nasofaríngeo / Metástasis Linfática Límite: Animals / Humans Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Virus de Epstein-Barr / Factor C de Crecimiento Endotelial Vascular / Linfangiogénesis / Carcinoma Nasofaríngeo / Metástasis Linfática Límite: Animals / Humans Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos